This information is intended for Colorado Prescribers

HB 19-1131

MARKETED PRESCRIPTION DRUG

COLORADO WAC DISCLOSURE FORM

DATE UPDATED

Diabetes Products

Form

1/4/2023

Vaccines

Form

1/1/2023

ALDURAZYME® (laronidase)

Form

1/16/2023

ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]

Form

1/4/2023

AUBAGIO® (teriflunomide)

Form

1/4/2023

CABLIVI® (caplacizumab-yhdp)

Form

1/4/2023

CERDELGA® (eliglustat) capsules, for oral use

Form

1/16/2023

Cerezyme® (imiglucerase) for injection

Form

1/19/2022

DUPIXENT® (dupilumab) Injection

Form

1/4/2023

ELITEK® (rasburicase) for injection

Form

1/4/2023

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]

Form

1/4/2023

ENJAYMO™ (sutimlimab-jome) injection, for intravenous use

Form

1/4/2023

FABRAZYME® (agalsidase beta) for injection, for intravenous use

Form

1/16/2023

JEVTANA® (cabazitaxel) Injection

Form

1/4/2023

KEVZARA® (sarilumab)

Form

1/4/2023

LEMTRADA® (alemtuzumab)

Form

1/4/2023

LOVENOX® (enoxaparin sodium injection) 

Form

7/15/2022

LUMIZYME® (alglucosidase alfa)

Form

1/16/2023

Mozobil® (plerixafor injection)

Form

1/4/2023

MULTAQ® (dronedarone)

Form

1/4/2023

NEXVIAZYME (avalglucosidase alfa-ngpt) for injection, for intravenous use

Form

1/16/2023

REZUROCK® (belumosudil) tablets

Form

1/4/2023

SARCLISA® (isatuximab-irfc) injection

Form

1/4/2023

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

Form

1/4/2023

THYROGEN® (thyrotropin alfa for injection)

Form

1/18/2023

XENPOZYME™ (olipudase alfa-rpcp) for injection, for intravenous use

Form

9/9/2022

House Bill 19-1131. Published by the General Assembly of the State of Colorado    

Please See Full Prescribing Information, including Boxed Warning, for AldurazymeAubagioElitekJevtanaKevzaraLemtradaLovenoxLumizymeMultaq,
 NexviazymeThymoglobulin , 
Xenpozyme

MAT-US-2007971-v7.0-12/2022